Liminatus Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	111	80	75	349
Market Cap Growth	-14.88%	6.12%	-78.38%	-
Enterprise Value	134	97	-	-
Last Close Price	4.40	11.22	10.33	10.12
PB Ratio	-	-4.14	-4.78	-32.30
Debt / Equity Ratio	-	-1.03	-1.02	-1.53
Quick Ratio	-	0.00	0.03	0.29
Current Ratio	-	0.21	0.12	0.39
Return on Assets (ROA)	-	-54.41%	-66.30%	-
Return on Capital (ROIC)	-	-468.22%	-101.31%	-
Earnings Yield	-3.18%	-4.43%	-6.60%	-0.84%
Buyback Yield / Dilution	74.62%	-9.49%	-188.25%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q